2.The Effect of Withdrawal of Angiotensin II Blockers on Serum Creatinine and Potassium in Patients with Chronic Kidney Diseases.
Hyuck Joon CHUNG ; Hee Sun JUNG ; Byoung Kook IM ; Heungsoo KIM ; Gyu Tae SHIN
Korean Journal of Nephrology 2006;25(4):561-569
BACKGROUND: Renin-ngiotensin system (RAS) blockers have been used to delay the progression of various renal diseases, but these medications cause hyperkalemia and the elevation of serum creatinine which impede the continuation of the medications. So far, there have been no data on the changes of serum creatinine or serum potassium after withdrawal of the RAS blockers. METHODS: We reviewed medical records of 60 patients who stopped the RAS blockers due to the elevation of serum creatinine or hyperkalemia between March 1995 and May 2005. They were assigned to either the elevated creatinine group or the hyperkalemia group according to the cause of the withdrawal. RESULTS: In the elevated creatinine group (n=37), the serum creatinine and GFR values at the point of withdrawal were 4.0+/-1.8 mg/dL and 18.2+/-10.4 mL/min/1.73m2, respectively. After discontinuation of the medications, a decrease in serum creatinine and an increase in GFR were noted at one month. After one month, however, serum creatinine increased continuously up to 6 months. Serum potassium levels decreased significantly after the drug withdrawal until the end of the study period. In the hyperkalemia group (n=23), the serum creatinine and serum potassium values at the point of withdrawal were 3.0+/-1.0 mg/dL and 6.4+/-0.4 mEq/L, respectively. A significant decrease in serum potassium was also noted after the withdrawal and this decrease lasted up to 6 months. But the transient decrease of serum creatinine, observed in the creatinine group, was not seen in this group. CONCLUSION: It was found that there was a beneficial effect on serum creatinine and GFR immediately after the withdrawal of RAS blockers only when they were stopped due to elevation of the serum creatinine concentration. The serum potassium levels were consistently decreased after the withdrawal of RAS blockers in both elevated creatinine and hyperkalemia groups.
Angiotensin II*
;
Angiotensin Receptor Antagonists
;
Angiotensins*
;
Creatinine*
;
Humans
;
Hyperkalemia
;
Medical Records
;
Potassium*
;
Renal Insufficiency, Chronic*
3.Effect of Preoperative Crystalline Lens Rise on Vaulting after Implantable Collamer Lens Implantation.
Ae Young KWAK ; Ik Hee RYU ; Jin Kook KIM ; Tae Im KIM ; Byoung Jin HA
Journal of the Korean Ophthalmological Society 2012;53(12):1749-1755
PURPOSE: To evaluate the parameters affecting vaulting and correlation between preoperative crystalline lens rise and vaulting after implantable collamer lense (ICL) implantation. METHODS: A total of 53 eyes of 34 patients who underwent ICL implantation were examined retrospectively. White-to-white (WTW) and anterior chamber depth (ACD) were obtained from scanning topography (ORB scan) before surgery. Preoperative crystalline lens rise (CLR) and vaulting at 6 months after ICL implantation were measured using anterior segment optic coherence tomography (AS-OCT). Multiple regression analysis was performed to evaluate the factors affecting central vaulting. RESULTS: The mean preoperative crystalline lens rise was -120 +/- 219 microm, and mean central vaulting 6 months after surgery was 544 +/- 175 microm. Preoperative SE, WTW, ACD, and CLR were significantly correlated with vaulting at 6 months after surgery. With the use of meaningful variables, multiple regression analysis showed that CLR, WTW, ACD and SE, in that order of influence, had significant effects on vaulting and the multiple regression equation was obtained as follows: Vaulting (microm) = (160.913 x ACD (mm)) + (170.134 x WTW (mm)) + (-0.338 x CLR (microm)) + (-23.783 x SE (D)) - 2250.184. CONCLUSIONS: CLR had a stronger influence on vaulting after ICL implantation than the previously proven parameters: WTW, ACD, and SE. In addition to WTW, ACD and SE, CLR should also be considered a new criterion for estimating vaulting after ICL implantation.
Anterior Chamber
;
Crystallins
;
Eye
;
Humans
;
Lens, Crystalline
;
Lenses, Intraocular
;
Retrospective Studies
4.Prevalence of nimesulide sensitivity in subjects diagnosed as having aspirin-sensitive asthma.
Byoung Kook IM ; Young Mok LEE ; Soo Keol LEE ; Dong Ho NAHM ; Hae Sim PARK
Journal of Asthma, Allergy and Clinical Immunology 2001;21(6):1161-1168
BACKGROUND AND OBJECTIVE: In patients with aspirin-sensitive asthma, anti-inflammatory treatment is a common problem in clinical practice. Nimesulide has been chosen due to weak inhibitory action on cyclooxygenase in ASA-sensitive asthma patients. In this study, we evaluated the safety of nimesulide in patients with ASA-sensitive asthma. METHODS: We performed lysine-aspirin bronchoprovocation test to confirm ASA-sensitive asthma, and nimesulide oral provocation test (up to 200 mg) to screen nimesulide sensitivity in 17 cases of bronchial asthma patients. RESULTS: Fifteen (88.2%) of 17 subjects showed positive responses to lysine-aspirin bronchoprovocation test. Six (35.3%) patients reacted to nimesulide oral provocation test. Of the six patients who reacted to nimesulide, three experienced bronchospasm, two urticaria, and one anaphylaxis. All positive reactions occurred within the 200 mg dose. One of 6 subjects showed a positive response to nimesulide oral provocation test without ASA-sensitivity. CONCLUSION: The prevalence of nimesulide sensitivity among aspirin-sensitive asthma was 33.3%, which was higher than in the previous reports. Screening oral provocation test is essential before prescribing relative COX-2 inhibitors for ASA-sensitive asthmatic patients. A case of nimesulide-sensitive asthma without ASA-sensitivity was also noted.
Anaphylaxis
;
Asthma*
;
Bronchial Spasm
;
Cyclooxygenase 2 Inhibitors
;
Humans
;
Mass Screening
;
Prevalence*
;
Prostaglandin-Endoperoxide Synthases
;
Urticaria
5.Mitoxantrone and cytosine arabinoside in adult patients with refractory and relapsed acute leukemia.
Jae Yong LEE ; Hyun Choon SHIN ; Young Suk PARK ; Jung Soon JANG ; Young Hyuck IM ; Sung Soo YOON ; Seoun Yang PARK ; Byoung Kook KIM ; Noe Kyeong KIM
Korean Journal of Hematology 1993;28(2):257-265
No abstract available.
Adult*
;
Cytarabine*
;
Cytosine*
;
Humans
;
Leukemia*
;
Mitoxantrone*
6.Role of PET Scan in Staging Work - up and Reevaluation after Therapy in Lymphoma.
Young Jin YUH ; Chul Won JUNG ; Seock Ah IM ; Dae Seog HEO ; Yung Jue BANG ; Seonyang PARK ; June Key CHUNG ; Myung Chul LEE ; Byoung Kook KIM ; Noe Kyeong KIM
Journal of the Korean Cancer Association 1999;31(5):1011-1017
PURPOSE: The authors evaluated the usefulness of the positron emission tomography (PET) with fluorine-18-tluorodeoxyglucose (8F-FDG) in initial staging, reevaluation after radical therapy and diagnosis of recurrence for non-Hodgkin's lymphoma, compaired to conventional imaging studies. MATERIALS AND METHODS: FDG-PET (ECAT Exact 47, Siemens) and conventional chest X-ray and computerized tomography (CT) were studied in patients with non-Hodgkins lymphoma. RESULTS: There were 17 patients (13 male, 4 female). Age was ranged from 18 to 62 years (median 49). By histological subgroup, diffuse large cell were 8 cases, peripheral T cell were 2 cases, diffuse mixed was 1 case, follicular mixed was 1 case, Burkitt's lymphoma was 1 case, Hodgkin's disease were 3 cases. The aims for PET were the initial staging work-up in 7 cases, the reevaluation of residual disease after radical therapy in 7 cases, the diagnosis of recurrence after complete remission in 3 cases. Between PET image and the conventional image, there were 3 cases with discrepancy, 1 case for initial staging work-up and 2 cases for the reevaluation of residual disease after radical therapy. Among the 3 cases with discrepancy, the 2 cases for the reevaluation of residual disease after radical therapy revealed that PET image reflects the involvement of lymphoma more accurately than the conventional image. CONCLUSION: The visual analysis of FDG-PET would be helpful in determining the residual disease of lymphoma after radical therapy.
Burkitt Lymphoma
;
Diagnosis
;
Hodgkin Disease
;
Humans
;
Lymphoma*
;
Lymphoma, Non-Hodgkin
;
Male
;
Positron-Emission Tomography*
;
Recurrence
;
Thorax
7.Risk Factors for Prognosis in Nosocomial Acinetobacter Bacteremia.
Seung Soo SHEEN ; Young Hwa CHOI ; Yoon Jung OH ; Keu Sung LEE ; Byoung Kook IM ; Kwang Joo PARK ; Sung Chul HWANG ; Yi Hyeoung LEE
Korean Journal of Infectious Diseases 2001;33(6):436-442
BACKGROUND: Acinetobacter bacteremia is an emerging nosocomial infection. We tried to find significant risk factors associated with the prognosis of patients with Acinetobacter bacteremia. METHODS: Retrospective case-control study was designed. The odds ratio estimation and multiple logistic regression for the categorical variables and Mann-Whitney test for the continuous variables were done. RESULTS: From September 1, 1999 to December 31, 2000 there were 25 adult patients with Acinetobacter bacteremia in Ajou University Hospital and 24 patients were confirmed as hospital acquired. The median age and hospital length of stay before bacteremia was 52 years old and 9.5 days respectively. There were 16 male patients. The overall mortality was 45.8 % (11 of 24). Thus there were 11 cases (death) and 13 controls (survival) of mortality. Statistical analysis revealed statistically significant differences between cases and controls in the terms of types of wards, central venous catheter, mechanical ventilation, total parenteral nutrition, and multi-resistant organisms. The multiple logistic regression analysis revealed that the more significant independent factors associated with mortality were mechanical ventilation and multi-resistant organisms. CONCLUSION: Acinetobacter bacteremia is a significant nosocomial infection. Especially mechanical ventilation and multi-resistant organisms were independent risk factors associated with high mortality with Acinetobacter bacteremia.
Acinetobacter*
;
Adult
;
Bacteremia*
;
Case-Control Studies
;
Central Venous Catheters
;
Cross Infection
;
Humans
;
Length of Stay
;
Logistic Models
;
Male
;
Middle Aged
;
Mortality
;
Odds Ratio
;
Parenteral Nutrition, Total
;
Prognosis*
;
Respiration, Artificial
;
Retrospective Studies
;
Risk Factors*
8.COP-BLAM V(cyclophosphamide/vincristine/prednisolone/bleomycin/ adriamycin/procarbazine) combination chemotherapy for the treatment of intermediate and high grade non-Hodgkin's lymphoma.
Young Iee PARK ; Kee Heung LEE ; Keong Hae JUNG ; Sung Soo YOON ; Yeong Huck IM ; Jung Soon JANG ; Jae Yong LEE ; Dae Suck HEO ; Yung Jue BANG ; Seonyang PARK ; Byoung Kook KIM ; Noe Kyeong KIM
Journal of the Korean Cancer Association 1992;24(2):268-276
No abstract available.
Drug Therapy, Combination*
;
Lymphoma, Non-Hodgkin*
9.Prognostic Factor Analysis of Aggressive Non - Hodgkin's Lymphoma Based on International Prognostic Index Model.
Min Hee RYU ; Young Iee PARK ; Hark Kyun KIM ; Dae Ho LEE ; Joo Young JEONG ; Dong Wan KIM ; Im Il NA ; Ji Hyun KIM ; Se Hoon LEE ; Dae Seog HEO ; Yung Jue BANG ; Seon Yang PARK ; Byoung Kook KIM ; Noe Kyeong KIM
Journal of the Korean Cancer Association 1998;30(6):1269-1278
PURPOSE: International Prognostic Index Model (IPIM) in aggressive non-Hodgkin's lymphoma was published and accepted generally as a better predictive model for prognosis. This study was undertaken to identify prognostic factors of aggressive non- Hodgkin's lymphoma and usefulness of IPIM in Korea. MATERIALS AND METHODS: Previously untreated, pathologically proven 226 aggressive non-Hodgkin's lymphoma patients who were treated with CHOP or COP-BLAM V between 1986 and 1995 in Seoul National University Hospital were evaluated for clinical features predictive of overall survival. RESULTS: Complete response (CR) was reached in 76% of all patients. With a median follow-up of 62 months, 5-year disease free survival of complete reponders was 67% and 5-year overall survival of all patients was 54%. In a univriate analysis, age, ECOG performance status, Ann Arbor stage, histologic subtype, bone marrow involvement, bulkiness, serum LDH level and number of extranodal involvement were significant prognostic factors for CR and survival (p<0.05). Of these, by multivariate analysis, age(RR 0.4, 95% CI 0.2~0.9) alone was a independent prognostic factor for CR. For disease free survival, no independent prognostic factor was found. For overall survival, Ann Arbor stage (RR 1.7, 95% CI 1.1~2.8), age (RR 1.7, 95% CI 1.1~2.6), Histologic subtype (RR 1.7, 95% CI 1.1~2.8), serum LDH level (RR 1.7, 95% CI 1.1~2.6) and bone marrow involvement (RR 1.8, 95% CI 1.0~3.1) were independent prognostic factors. According to risk group of IPIM, 5-year overall survival rate was 72% in low risk group, 46% in low intermediate risk group, 32% in high intermediate risk group, respectively, and median survival of high risk group was 12 months (RR 1, 2.3, 4.3, 6.4 respectively). CONCLUSION: IPIM is a useful model for identifying poor prognostic groups in aggressive non-Hodgkin's lymphoma.
Bone Marrow
;
Disease-Free Survival
;
Factor Analysis, Statistical*
;
Follow-Up Studies
;
Hodgkin Disease*
;
Humans
;
Korea
;
Lymphoma, Non-Hodgkin
;
Multivariate Analysis
;
Prognosis
;
Seoul
;
Survival Rate
10.Clinicopathologic Charcteristics of Korean Non - Hodgkin's Lymphomas Based on REAL Classification.
Yoon Koo KANG ; Bong Seog KIM ; Tae Won KIM ; Mon Hee RYU ; Seung Sook LEE ; Baek Yeol RYOO ; Tae You KIM ; Young Hyuck IM ; Kyoo Hyung LEE ; Jooryung HUH ; Dae Seog HEO ; Yung Jue BANG ; Chulwoo KIM ; Jung Shin LEE ; Byoung Kook KIM ; Woo Kun KIM ; Sang Hee KIM ; Noe Kveong KIM
Journal of the Korean Cancer Association 1999;31(4):641-652
PURPOSE: Non-Hodgkins lymphoma (NHL) is recognized as not a single disease but a group of diseases heterogeneous in biology and clinical characteristics. Recently, a new pathologic classification system, the REAL classification, has been introduced into the clinic. Although REAL classification has tried to define the subtypes biologically more correctly, its clinical usefulness has not been established yet. A retrospective study was performed to define the clinical characteristics of Korean NHLs according to the REAL classification and to determine its clinical usefulness. MATERIALS AND METHODS: Pathologies of NHLs managed at 3 major hospitals in Korea between 1989 and 1995 were reviewed with immunophenotyping to determine the pathologic subtypes according to REAL classification. Clinical characteristics at the presentation and treatment outcomes of the eligible patients were analyzed. To determine the differences from the NHLs in the western countries, data of Non-Hodgkins Lymphoma Classification Project (NHLCP) were also compared. RESULTS: Total 802 cases were eligible for this study. Although it was similar to NHLCP study that B-cell subtypes were the majority and diffuse large B-cell lymphoma was the most common subtype, the proportion of T-cell subtypes were much higher in our patient population than in the western population. It was because peripheral T-cell lymphomas, angiocentric lymphoma in particular, were more common and follicular lymphomas were less common in our patients. Eleven common pathologic subtypes could be classified into 3 prognostic groups. Marginal zone B-cell lymphoma and lymphoplasmacytoid lymphoma of which 5-year overall survival rate (5-yOSR) were > 80% were classified in the good prognostic group. Precursor T-lymphoblastic lymphoma was classified in the poor prognostic group because its 5-yOSR was less than 30%. The other 9 subtypes were classified in the intermediate prognostic group with S-yOSR of 30-79%. CONCLUSION: The clinical. character' tics and prognoses of Korean NHLs could be defined according to REAL classification. These information would be helpful for the clinicians in formulating treatment strategies of Korean NHLs according to REAL classification.
B-Lymphocytes
;
Biology
;
Classification*
;
Hodgkin Disease*
;
Humans
;
Immunophenotyping
;
Korea
;
Lymphoma
;
Lymphoma, B-Cell
;
Lymphoma, B-Cell, Marginal Zone
;
Lymphoma, Follicular
;
Lymphoma, Non-Hodgkin
;
Lymphoma, T-Cell, Peripheral
;
Pathology
;
Prognosis
;
Retrospective Studies
;
Survival Rate
;
T-Lymphocytes
;
Tics
;
Waldenstrom Macroglobulinemia